Incretin drugs as modulators of atherosclerosis.
Sign Up to like & getrecommendations! Published in 2018 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2018.09.011
Abstract: Atherosclerosis is a major underlying cause of ischemic heart diseases, ischemic stroke, and peripheral artery disease. Atherosclerotic plaque progression is characterized by chronic progressive inflammation of the arterial wall, endothelial cell dysfunction, and subendothelial lipoprotein… read more here.
Keywords: incretin drugs; drugs modulators; incretin; modulators atherosclerosis ... See more keywords
Anti-atherosclerotic effect of incretin mimetics: a meta-analysis of randomized controlled trials
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Community Hospital Internal Medicine Perspectives"
DOI: 10.1080/20009666.2018.1542919
Abstract: ABSTRACT Background: Diabetes is a very common cause of cardiovascular disease, and metformin remains the first-line treatment of diabetes. Many trials were conducted to prove the efficacy and safety of other antidiabetic medication as the… read more here.
Keywords: effect incretin; randomized controlled; atherosclerotic effect; incretin mimetics ... See more keywords
A Novel Dual Incretin Agent, Tirzepatide (LY3298176), for the Treatment of Type 2 Diabetes Mellitus and Cardiometabolic Health
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cardiovascular Pharmacology"
DOI: 10.1097/fjc.0000000000001299
Abstract: Abstract: The incretin hormone system is the target of multiple type 2 diabetes mellitus (T2DM) treatments because defects in this system play major roles in the pathogenesis of diabetes. Currently, the glucagon-like peptide-1 receptor agonists… read more here.
Keywords: agent; incretin; incretin agent; type diabetes ... See more keywords
Loss of incretin effect contributes to postprandial hyperglycaemia in cystic fibrosis‐related diabetes
Sign Up to like & getrecommendations! Published in 2019 at "Diabetic Medicine"
DOI: 10.1111/dme.14121
Abstract: To investigate the incretin axis in people with cystic fibrosis. read more here.
Keywords: effect contributes; cystic fibrosis; incretin effect; loss incretin ... See more keywords
Protective effect of incretin aganist age-related disease.
Sign Up to like & getrecommendations! Published in 2019 at "Current drug delivery"
DOI: 10.2174/1567201816666191010145029
Abstract: Incretin contains two peptides named glucagon-like peptide-1and glucose-dependent insulinotropic polypeptide. Incretin-based therapies have become a new class of antidiabetic drugs for its promising action on insulinotropic secretion and improving insulin receptor. Considering the fact which… read more here.
Keywords: effect incretin; related disease; age related; protective effect ... See more keywords
Genetic Variability of Incretin Receptors and Alcohol Dependence: A Pilot Study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Molecular Neuroscience"
DOI: 10.3389/fnmol.2022.908948
Abstract: Alcohol dependence is a chronic mental disorder that leads to decreased quality of life for patients and their relatives and presents a considerable burden to society. Incretin hormones, such as glucose-dependent insulinotropic polypeptide (GIP) and… read more here.
Keywords: genetic variability; dependence; incretin; alcohol dependence ... See more keywords
Incretin based therapy and pancreatic cancer: Realising the reality
Sign Up to like & getrecommendations! Published in 2022 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v28.i25.2881
Abstract: Incretin-based therapies like glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors help maintain the glycaemic control in patients with type 2 diabetes mellitus with additional systemic benefits and little risk of hypoglycaemia. These medications are… read more here.
Keywords: incretin based; based therapy; pancreatic cancer; cancer realising ... See more keywords